In the past decade antisense oligonucleotides asos have proven to est by exploiting the. Small pieces of dna or rna that can bind to specific molecules of rna. Basic concepts and mechanisms find, read and cite all the research you. Asos are small singlestranded pieces of dna that bind via complementary basepair binding to the intracellular mrna transcript figure. Nucleic acid therapeutics making sense of antisense acs webinar, july 28th 2016 punit seth, ph. Antisense oligonucleotides, antisense technology bio. Genes contain the information necessary to produce proteins. Pdf on apr 1, 2002, nathalie dias and others published antisense oligonucleotides.
An analytical procedure by the inductively coupled plasma. The use of antisense oligonucleotides for gene silencing. This blocks the ability of the rna to make a protein or work in other ways. Jci antisense oligonucleotides extend survival and. Antisense oligonucleotides aons can interfere with mrna processing through rnase hmediated degradation, translational arrest, or modulation of splicing. Many antisense oligonucleotides asos from several classes of molecules. The recurring issues of target accessibility, probe design, offtarget effects and the proper use of chemical modifications are solved in the antisense architect which uses design heuristics that allows for the rational design of antisense oligonucleotides. The use of antisense oligonucleotides asos is a promising approach to gene silencing.
Antisense oligonucleotides have been used to modify the expression of specific genes. Antisense transcripts have also been identified in brassica for the s locus receptor kinase gene which controls selfincompatibility in brassica cock et al. Rnasehmediated degradation of complementary mrna is the major mode of action of antisense oligonucleotides. Hybridization of the aso to the target rna mediates rnase h cleavage of the rna, which can inhibit the function of noncoding rnas e. Backgroundepidemiologic and genomewide association studies have linked lossoffunction variants in angptl3, encoding angiopoietinlike 3, with low levels of plasma lipoproteins. The concept underlying antisense technology is relatively straightforward. Protein production occurs in two phases called transcription and translation. Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms received for publication, may 7, 1991.
Applied antisense oligonucleotide technology provides the basic concepts as well as the practical concerns associated with the use of antisense oligonucleotides to modify gene expression. Nextgeneration sod1 asos more potently reduce mrna and protein in rodent models compared with previous asos. When the genetic sequence of a particular gene is known to cause a particular disease, it is possible to synthesize a strand of nucleic acid dna, rna or a chemical analogue that will bind to the messenger rna mrna produced by that gene and inactivate it, effectively turning that gene off. If binding takes place this hybrid can be degraded by the enzyme rnase h. In antisense technology, singlestranded dna or rna molecules are used to target a specific sense mrna. Antibodyantisense oligonucleotide conjugate downregulates. We developed antibodyantisense oligonucleotide aon conjugates to target and reduce drrfam107a expression. Advances have been made in defining the best target sequences for use in antisense oligonucleotide technology, and new chemical derivatives of oligonucleotides are. Enzymemediated reduction of target rnas involves rnase h1 or rna induced silencing complex riscdependent mechanisms 1,5. The recent developments in the human genome sequencing, the possibility of a rational design of oligonucleotides and the theoretical simplicity, and relatively cheap costs of these compounds led to their use as either therapeutic agents or tools for assessing gene function. Aso technology provided the first oligonucleotidebased approach to disrupting gene expression and has been used in knockdown experiments, target validation, drug therapy, and other applications.
Definition of antisense oligonucleotide nci dictionary. Antisense oligonucleotides microsynth ag microsynth ch. There are several aspects of antisense therapy utilizing oligonucleotides that are potentially advantageous over traditional drug mechanisms. There has been a recent revival of interest in the use of antisense oligonucleotides to treat neurodegenerative disorders. The journal of biological chemistry 8 1991 by the american society for biochemistry and molecular biology, inc. In a human neuroblastoma cell line shsy5y, these new asos aso 1. Nucleic acids therapeutics making sense of antisense. Mechanisms and strategies for effective delivery of. The antisense effect of a synthetic oligonucleotide sequence was first demonstrated in the late 1970s by zamecnik and stephenson 1. Our study is the first clinical report of delivery of antisense oligonucleotides to the csf. Crooke, molecular mechanisms of antisense oligonucleotides, nucleic acid therapeutics 2017. Second generation antisense oligonucleotides offer other mechanisms of action to inhibit the production of proteins thus having a potential an alternative antisense therapy to psodns. In the transcription phase, the dna strand is used as a template for manufacturing an mrna molecule. Rnase h1dependent antisense oligonucleotides asos are active in reducing levels of both cytoplasmic mrnas and nuclear retained rnas.
Antisense oligonucleotides may be used to block the production of proteins needed for cell growth. Cardiovascular and metabolic effects of angptl3 antisense. Antisense oligonucleotides phosphorothioate the driving force for the search for novel chemical modification groups compatible with watsoncrick hybridization of oligonucleotide was based on the observation of the short stability of naturally occurring oligonucleotides with. With these modifications, antisense oligonucleotides can. Rnase h1dependent antisense oligonucleotides are robustly. Microinjecting oligonucleotides into cells results in rapid accumulation of the oligonucleotide in the nucleus 7. Antisense oligonucleotides offer new opportunities for therapeutic intervention because they act inside the cell to influence protein production. Antisense oligonucleotides are synthetic single stranded strings of nucleic acids, between 8 and 50 nucleotides in length, that bind to rna through standard watsoncrick base pairing. Oligonucleotidebased drugs, in particular antisense oligonucleotides, are part of a growing number of pharmaceutical and biotech programs progressing to treat a wide range of indications including cancer, cardiovascular, neurodegenerative, neuromuscular, and respiratory diseases, as well as other severe and rare diseases. Normally, antisense oligonucleotides contain 15 to 22. Oligonucleotides incorporating 2omethoxyethyl moemodified nucleotides, can support most, if not all antisense mechanisms of action.
Chapters include oligonucleotide chemistry, dna triplex formation, delivery mechanisms, pharmocokinetics, toxicity, oligonucleotides. The principle of antisense technology is the sequencespecific binding of an antisense oligonucleotide to target mrna, resulting in the. Antisense oligonucleotides inhibit intercellular adhesion. Possible sights of interference for antisense oligonucleotides initiation of translation or elongation, rna processing, ribonucleoprotein function, and. Mipomersen is an antisense oligonucleotide inhibitor of apo b100 synthesis, an essential component of lipoproteins such as verylowdensity lipoprotein vldl and ldl. Antisense oligonucleotides integrated dna technologies. Antisense oligonucleotides refer to short, synthetic oligonucleotide that are complementary in sequence and upon specific hybridization to its cognate gene product induces inhibition of gene expression.
Using kinetic and subcellular fractionation studies, we evaluated aso activity in the cytoplasm. Antisense technology, in which antisense oligonucleotides asos hybridize with target rnas to result in specificity, can modulate gene expression via different mechanisms. However, any agent that is capable of targeting a specific premrna sequence will work. The technology focuses on a class of chemicals, oligonucleotides, that have not been studied as potential drugs before and uses them to intervene in processes that, likewise, have not been studied as sites at which drugs might act. Antisense oligonucleotides are synthetic polymers in which some or all of the natural nucleotide monomers of the oligonucleotide are chemicallymodified deoxynucleotides in dna or ribonucleotides in rna.
A search for antisense oligonucleotide and glioma returned one clinical trial using convectionenhanced delivery of an antisense oligonucleotide directly to a cns tumour. Strong pipeline of antisense oligonucleotides and increased focused on large number of product approvals and commercialization are some of the primary factors driving the growth of the global antisense oligonucleotides market. The antisense approach relies on aons to efficiently bind to target sequences and depends on aon length, sequence content, secondary structure, thermodynamic properties, and target. Rnases h is an enzyme that hydrolyzes rna, and when used in an antisense oligonucleotide application results in 8095% downregulation of mrna expression. This would be achieved by the binding of the antisense oligonucleotide to the mrna from which that protein is normally synthesized. Antisense oligonucleotides asos are dna oligos, typically 1525 bases long, designed in antisense orientation to the rna of interest. Based on an in vitro screen of over 2,000 asos targeting the human sod1 gene and subsequent optimization, 2 particularly potent asos targeting the 3. Chemical structure of 2 moe oligonucleotide in comparison with rna. Oligonucleotide drugs can work through multiple mechanisms antisense oligonucleotides bind to rna by watsoncrick basepairing and. Antisense technology, in which antisense oligonucleotides asos hybridize with target rnas to result in specificity, can modulate gene expression via different mechanisms 12 3 4. Unraveling the mechanism of antisense oligonucleotides. Glioblastoma stem cells gscs are invasive, treatmentresistant brain cancer cells that express downregulated in renal cell carcinoma drr, also called fam107a, a genetic driver of gsc invasion. Oligonucleotides, as short as 15 mer have the required specificity to inhibit gene expression of a particular gene by annealing to the cellular. Specifically, we used antibodies against antigens expressed.
In this analytical procedure, the sample solutions obtained from the rinse sampling and direct surface sampling. The regulation of antisense rna involves certain basic mechanisms, on the basis of which they have been classified into three classes takamaya and inouye, 1990. Further key distinctive characteristics are nuclease resistance, lower toxicity, superior target binding specificity, as well as increased affinity towards complementary rna. The therapeutic use of oligonucleotides represents a new paradigm for drug discovery. Guidelines for antisense oligonucleotide design and. Here, we briefly summarize aspects of the chemistry and biology of antisense and sirna oligonucleotides that are salient to their potential as therapeutic agents. Antisense oligonucleotides, or asos, are 1525 nt dna sequences designed to bind complementary rna targets, ultimately facilitating their degradation. Over 10 million scientific documents at your fingertips. However, although antisense oligonucleotides are commonly in. On the basis of mechanism of action, two classes of antisense oligonucleotide can be discerned. Chemistry, mechanism and clinical status of antisense.
Basic mechanisms of action for therapeutic antisense oligonucleotides asos and rna interference rnai. Antisense oligonucleotides asos were first discovered to influence rna processing and modulate protein expression over two decades ago. The concept of using synthetic oligonucleotides to control the expression of genes. Antisense drugs are short, chemically modified, singlestranded nucleic acids antisense oligonucleotides that have the ability to target any gene product of interest. Concepts and mechanisms cleotide concentration, these receptors are saturated, and the pinocytotic process assumes larger importance. Antisense oligonucleotides oligonucleotidebased antisense techniques represent the most common and, to date, the most successful approach to achieving suppression or elimination of a genetic message.
Discovery and analysis of antisense oligonucleotide activity in cell. Although aso activity in the nucleus has been well demonstrated, the cytoplasmic activity of asos is less clear. By using a gel delivery system to deliver the cmyb antisense oligonucleo tides to the outer surface of the ballooninjured ar tery, these investigators reduced the development of infimal hyperplasia to 15% that of control samples. Antisense therapy is a form of treatment for genetic disorders or infections. Antisense oligonucleotides can be used to target a specific, complementary coding or noncoding rna. An analytical procedure by the inductively coupled plasma mass spectrometry icpms is provided to quantitate the remaining phosphorus amount on the surface of the manufacturing equipment for the oligonucleotide active pharmaceutical ingredient api. An antisense oligonucleotide against sod1 delivered. They are being studied in the treatment of several types of cancer.
176 227 962 764 1442 1324 1082 1180 1005 708 151 184 919 957 771 3 92 1500 1531 177 152 466 815 886 1470 1025 1485 238 1024 1422